Published in Blood Weekly, August 17th, 2000
"Because tumor contamination of hematopoietic stem cell grafts may influence the outcome in breast carcinoma (BC) patients undergoing high-dose chemotherapy (HDC), several ex vivo procedures for the purging of autologous harvests have been investigated," wrote P. Pedrazzoli and colleagues, Osped Niguarda Ca Granda, Italy ("Negative immunomagnetic purging of peripheral blood stem cell harvests from breast carcinoma patients reduces tumor cell...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.